Phase 3, randomised trial of avelumab versus physicianʼs choice of chemotherapy as third-line treatment for patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300 - Bang, Y J; Ruiz, E Y; Van Cutsem, E (Ann Oncol, 2018)
et al.